Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 14/20 | 0.77 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.63 |
| ▸ | DRD1 | P21728 | 1/20 | 0.63 |
| ▸ | HTR2A | P28223 | 1/20 | 0.63 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.63 |
| ▸ | TLR8 | Q9NR97 | 3/20 | 0.53 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13975714 | 1.00 | KCNH2 (0.77) | KCNH2CYP2D6DRD1HTR2AADORA1 | |
| SCHEMBL13975891 | 0.87 | KCNH2 (1.00) | KCNH2CYP2D6DRD1HTR2AADORA1 | |
| SCHEMBL19723158 | 0.87 | KCNH2 (1.00) | KCNH2CYP2D6DRD1HTR2AADORA1 | |
| SCHEMBL13975093 | 0.86 | KCNH2 (1.00) | KCNH2CYP2D6DRD1HTR2AADORA1 | |
| SCHEMBL19723033 | 0.86 | KCNH2 (0.77) | KCNH2CYP2D6DRD1HTR2AADORA1 | |
| SCHEMBL13975082 | 0.85 | KCNH2 (0.76) | KCNH2CYP2D6DRD1HTR2AADORA1 | |
| SCHEMBL13975821 | 0.85 | KCNH2 (0.76) | KCNH2CYP2D6DRD1HTR2AADORA1 | |
| SCHEMBL13975543 | 0.85 | KCNH2 (0.65) | KCNH2CYP2D6DRD1HTR2AADORA1 | |
| SCHEMBL15502397 | 0.84 | KCNH2 (0.88) | KCNH2CYP2D6DRD1HTR2AADORA1 | |
| SCHEMBL19723036 | 0.84 | KCNH2 (0.88) | KCNH2CYP2D6DRD1HTR2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012156498-A1 | QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES | JANSSEN R&D IRELAND (IE) | 2012-11-22 | — | — | WO | disclosed |